One analyst said that new data on an Eli Lilly cancer drug “could not have been better,” but the pharma giant’s stock was mildly lower in Monday morning trading.

source https://finance.yahoo.com/m/1ad12b54-8e3e-309d-8b3b-8c486ed0af0d/eli-lilly-stock-shrugs-off.html?.tsrc=rss